BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3100907)

  • 1. [New active drugs against the tuberculosis bacillus and other mycobacteria].
    de Kantor IN
    Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of in vitro antimycobacterial activities of ansamycin and rifampicin].
    Tsukamura M; Mizuno S; Toyama H; Ichiyama S
    Kekkaku; 1986 Oct; 61(10):497-503. PubMed ID: 3100853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H; Sato K; Tomioka H; Watanabe T
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
    Sula L; Sulová J
    Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480.
    Sbardella G; Mai A; Artico M; Loddo R; Setzu MG; La Colla P
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1537-41. PubMed ID: 15006398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of mycobacterial isolates from AIDS patients.
    Scavizzi A; Baldelli F; Capparelli G; Merletti L; Pasticci MB; Polidori M; Tascini C; Sbaraglia G
    J Chemother; 1995 Nov; 7 Suppl 4():87-9. PubMed ID: 8904118
    [No Abstract]   [Full Text] [Related]  

  • 12. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS; Berlin OG; Inderlied CB
    Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the germ-carrier method for testing of the activity of disinfectants against mycobacteria strains].
    Gevaudan MJ; Gulian C; Mallet MN; Peres P; Estrangin E; de Micco P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):896-900. PubMed ID: 3116490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro].
    Ungheri D; Morvillo E; Sanfilippo A
    G Ital Chemioter; 1983; 30(2-3):97-100. PubMed ID: 6329872
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
    Zhao T; Yang SR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antimycobacterial activities of minocycline and ciprofloxacin].
    Arai T; Komatsu S; Aoyagi T
    Kekkaku; 1985 May; 60(5):293-7. PubMed ID: 3162057
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
    Cavicchioli M; Leite CQ; Sato DN; Massabni AC
    Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam antibiotics and mycobacteria.
    Finch R
    J Antimicrob Chemother; 1986 Jul; 18(1):6-8. PubMed ID: 3093446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.